The present study suggests that MPT63 and MPT64 mediate the regulation of IFN-β and ROS in the host macrophages and that rMPT derived from MPT63 and MPT64 may be a candidate for a novel vaccine or a therapeutic agent against TB. This evidence concerns the gene IFNB1 and tuberculosis.